Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Christian Rolfo, Giovanni Sortino, Evelien Smits, Francesco Passiglia, Giuseppe Bronte, Marta Castiglia, Antonio Russo, Edgardo S Santos, Annelies Janssens, Patrick Pauwels & Luis Raez. (2014) Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?. Expert Review of Anticancer Therapy 14:10, pages 1173-1187.
Read now
Read now
Francisco Socola, Naomi Scherfenberg & Luis E Raez. (2013) Therapeutic vaccines in non-small cell lung cancer. ImmunoTargets and Therapy 2, pages 115-124.
Read now
Read now
Brian M Olson & Douglas G McNeel. (2011) Sipuleucel-T: immunotherapy for advanced prostate cancer. Open Access Journal of Urology 3, pages 49-60.
Read now
Read now
Nathalie Garçon & Marcelle Van Mechelen. (2011) Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems. Expert Review of Vaccines 10:4, pages 471-486.
Read now
Read now
Morten Frier Gjerstorff, Jorge Burns & Henrik Jorn Ditzel. (2010) Cancer–germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment. Expert Opinion on Biological Therapy 10:7, pages 1061-1075.
Read now
Read now
Olivia Simmons, Mitchell Magee & John Nemunaitis. (2010) Current vaccine updates for lung cancer. Expert Review of Vaccines 9:3, pages 323-335.
Read now
Read now
Christian M Capitini, Crystal L Mackall & Alan S Wayne. (2010) Immune-based therapeutics for pediatric cancer. Expert Opinion on Biological Therapy 10:2, pages 163-178.
Read now
Read now
Kun Wang, Qing Zhou, Ai-Lin Guo, Chong-Rui Xu, She-Juan An & Yi-Long Wu. (2009) An Autologous Therapeutic Dendritic Cell Vaccine Transfected with Total Lung Carcinoma RNA Stimulates Cytotoxic T Lymphocyte Responses Against Non-Small Cell Lung Cancer. Immunological Investigations 38:7, pages 665-680.
Read now
Read now
Articles from other publishers (44)
Chongming Jiang, Jianrong Li, Wei Zhang, Zhenkun Zhuang, Geng Liu, Wei Hong, Bo Li, Xiuqing Zhang & Cheng-Chi Chao. (2022) Potential association factors for developing effective peptide-based cancer vaccines. Frontiers in Immunology 13.
Crossref
Crossref
Brennan S. Dirk, Genevieve Weir, Tara Quinton, Olga Hrytsenko & Marianne M. Stanford. (2021) Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model. Scientific Reports 11:1.
Crossref
Crossref
Qinghua He, Xianhan Jiang, Xinke Zhou & Jinsheng Weng. (2019) Targeting cancers through TCR-peptide/MHC interactions. Journal of Hematology & Oncology 12:1.
Crossref
Crossref
Matteo Bellone & Sara Caputo. 2019. Cancer Stem Cell Resistance to Targeted Therapy. Cancer Stem Cell Resistance to Targeted Therapy
173
221
.
Leena Gandhi, Johan F. Vansteenkiste & Frances A. Shepherd. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology
501
511.e3
.
Chin-Yu Wang, Bai-Ling Lin & Chung-Hsuan Chen. (2016) An aptamer targeting shared tumor-specific peptide antigen of MAGE-A3 in multiple cancers. International Journal of Cancer 138:4, pages 918-926.
Crossref
Crossref
Yuh-Pyng Sher, Su-I Lin, I-Hua Chen, Hsin-Yu Liu, Chen-Yuan Lin, I-Ping Chiang, Steve Roffler, Hsin-Wei Chen & Shih-Jen Liu. (2015) A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model. Oncotarget 7:1, pages 671-683.
Crossref
Crossref
Zhenlong Ye, Zhong Li, Huajun Jin & Qijun Qian. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy
139
167
.
Matthias GieseMatthias Giese. 2016. Introduction to Molecular Vaccinology. Introduction to Molecular Vaccinology
145
163
.
Lawrence Segal, Virginie Roger, Colin Williams, Eric Destexhe & Nathalie Garçon. (2015) Effects of Adjuvant Systems on the cardiovascular and respiratory functions in telemetered conscious dogs and anaesthetised rats. Regulatory Toxicology and Pharmacology 73:1, pages 116-125.
Crossref
Crossref
Shohei Domae, Toshiro Ono & Akira Sasaki. (2014) Cancer/testis antigens: A prospective reagent as diagnostic and immunotherapeutic targets for squamous cell carcinoma of the head and neck. Japanese Dental Science Review 50:4, pages 91-99.
Crossref
Crossref
Hadeel Khallouf, Agnieszka Grabowska & Angelika Riemer. (2014) Therapeutic Vaccine Strategies against Human Papillomavirus. Vaccines 2:2, pages 422-462.
Crossref
Crossref
Jeffrey Schlom, James W. Hodge, Claudia Palena, Kwong-Yok Tsang, Caroline Jochems, John W. Greiner, Benedetto Farsaci, Ravi A. Madan, Christopher R. Heery & James L. Gulley. 2014.
67
124
.
Jesús Arenas. 2014. Molecular Vaccines. Molecular Vaccines
527
536
.
David Rönsberg, Abdessamad Debbab, Attila Mándi, Vera Vasylyeva, Philip Böhler, Björn Stork, Laura Engelke, Alexandra Hamacher, Richard Sawadogo, Marc Diederich, Victor Wray, WenHan Lin, Matthias U. Kassack, Christoph Janiak, Stefanie Scheu, Sebastian Wesselborg, Tibor Kurtán, Amal H. Aly & Peter Proksch. (2013) Pro-Apoptotic and Immunostimulatory Tetrahydroxanthone Dimers from the Endophytic Fungus Phomopsis longicolla. The Journal of Organic Chemistry 78:24, pages 12409-12425.
Crossref
Crossref
Otavia L. Caballero, Tzeela Cohen, Sita Gurung, Ramon Chua, Peishan Lee, Yao-Tseng Chen, Parmjit Jat & Andrew J. G. Simpson. (2013) Effects of CT-Xp Gene Knock down in Melanoma Cell Lines. Oncotarget 4:4, pages 531-541.
Crossref
Crossref
Faten El Hage, Aur?lie Durgeau & Fathia Mami-Chouaib. (2013) TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes. Annals of the New York Academy of Sciences 1283:1, pages 75-80.
Crossref
Crossref
Ursula Wiedermann, Adam B. Davis & Christoph C. Zielinski. (2013) Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines. Breast Cancer Research and Treatment 138:1, pages 1-12.
Crossref
Crossref
Gisela Gonzalez, Arlhee Diaz-Miqueli, Tania Crombet, Luis E. Raez & Agustin Lage. (2013) Current Algorithm for Treatment of Advanced NSCLC Patients: How to Include Active Immunotherapy?. Journal of Cancer Therapy 04:08, pages 59-75.
Crossref
Crossref
Chunqing Guo, Masoud H. Manjili, John R. Subjeck, Devanand Sarkar, Paul B. Fisher & Xiang-Yang Wang. 2013.
421
475
.
Francesco M Marincola & Javaid I Sheikh. (2012) A road map to Translational Medicine in Qatar and a model for the world. Journal of Translational Medicine 10:1.
Crossref
Crossref
David W. Meek & Lynnette Marcar. (2012) MAGE-A antigens as targets in tumour therapy. Cancer Letters 324:2, pages 126-132.
Crossref
Crossref
Tommaso De Pas, Monica Giovannini, Maria Rescigno, Chiara Catania, Francesca Toffalorio, Gianluca Spitaleri, Angelo Delmonte, Massimo Barberis, Lorenzo Spaggiari, Piergiorgio Solli, Giulia Veronesi & Filippo De Braud. (2012) Vaccines in non-small cell lung cancer: Rationale, combination strategies and update on clinical trials. Critical Reviews in Oncology/Hematology 83:3, pages 432-443.
Crossref
Crossref
Sandhiya Selvarajan, Melvin George, Suresh Kumar S. Steven Aibor Dkhar. (2012) Recent Advances in Cancer Vaccines - An Update. Journal of Cancer Research Updates 1:2, pages 173-180.
Crossref
Crossref
L. Decoster, I. Wauters & J.F. Vansteenkiste. (2012) Vaccination therapy for non-small-cell lung cancer: review of agents in phase III development. Annals of Oncology 23:6, pages 1387-1393.
Crossref
Crossref
J. Schlom. (2012) Therapeutic Cancer Vaccines: Current Status and Moving Forward. JNCI Journal of the National Cancer Institute 104:8, pages 599-613.
Crossref
Crossref
Jochen T. Schaefer. 2012. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
295
304
.
Pedro de Sousa Alves & Vincent Brichard. 2011. Cancer Vaccines. Cancer Vaccines
87
102
.
Pedro de Sousa Alves & Vincent Brichard. 2011. Cancer Vaccines: From Research to Clinical Practice. Cancer Vaccines: From Research to Clinical Practice
87
102
.
Sylvia Adams, Luba Greeder, Elsa Reich, Yongzhao Shao, Denise Fosina, Nicole Hanson, Jodie Tassello, Baljit Singh, Giulio C. Spagnoli, Sandra Demaria & Achim A. Jungbluth. (2011) Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?. Cancer Immunology, Immunotherapy 60:7, pages 999-1007.
Crossref
Crossref
Thomas F. Gajewski. (2011) Molecular Profiling of Melanoma and the Evolution of Patient-Specific Therapy. Seminars in Oncology 38:2, pages 236-242.
Crossref
Crossref
Zoltán Pós & Jérôme Galon. 2011. Immunologic Signatures of Rejection. Immunologic Signatures of Rejection
199
210
.
Otavia L. Caballero, Qi Zhao, Donata Rimoldi, Brian J. Stevenson, Suzanne Svobodov?Sylvie Devalle, Ute F. R?hrig, Anna Pagotto, Olivier Michielin, Daniel Speiser, Jedd D. Wolchok, Cailian Liu, Tanja Pejovic, Kunle Odunsi, Francis Brasseur, Benoit J. Van den Eynde, Lloyd J. Old, Xin Lu, Jonathan Cebon, Robert L. Strausberg & Andrew J. Simpson. (2010) Frequent MAGE Mutations in Human Melanoma. PLoS ONE 5:9, pages e12773.
Crossref
Crossref
V.G. Brichard & D. Lejeune. (2010) New data on MAGE-A3 cancer immunotherapy may signal new options for patients with melanoma and non-small cell lung cancer. Revue des Maladies Respiratoires Actualit?s 2:3, pages 282-285.
Crossref
Crossref
Geert Leroux-Roels. (2010) Unmet needs in modern vaccinology. Vaccine 28, pages C25-C36.
Crossref
Crossref
Fred Zepp. (2010) Principles of vaccine design—Lessons from nature. Vaccine 28, pages C14-C24.
Crossref
Crossref
Cécile Badoual, Federico Sandoval, Helene Pere, Stephane Hans, Alain Gey, Nathalie Merillon, Cordelia Van Ryswick, Françoise Quintin‐Colonna, Patrick Bruneval, Daniel Brasnu, Wolf H. Fridman & Eric Tartour. (2010) Better understanding tumor–host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies. Head & Neck 32:7, pages 946-958.
Crossref
Crossref
Thomas W. DubenskyJrJr & Steven G. Reed. (2010) Adjuvants for cancer vaccines. Seminars in Immunology 22:3, pages 155-161.
Crossref
Crossref
Bor-Yu Tsai, Yu-Li Lin & Bor-Luen Chiang. (2010) Autoimmune response induced by dendritic cells exerts anti-tumor effect in murine model of leukemia. Journal of Autoimmunity 34:4, pages 364-370.
Crossref
Crossref
Hideaki Tahara, Marimo Sato, Magdalena Thurin, Ena Wang, Lisa H Butterfield, Mary L Disis, Bernard A Fox, Peter P Lee, Samir N Khleif, Jon M Wigginton, Stefan Ambs, Yasunori Akutsu, Damien Chaussabel, Yuichiro Doki, Oleg Eremin, Wolf Hervé Fridman, Yoshihiko Hirohashi, Kohzoh Imai, James Jacobson, Masahisa Jinushi, Akira Kanamoto, Mohammed Kashani-Sabet, Kazunori Kato, Yutaka Kawakami, John M Kirkwood, Thomas O Kleen, Paul V Lehmann, Lance Liotta, Michael T Lotze, Michele Maio, Anatoli Malyguine, Giuseppe Masucci, Hisahiro Matsubara, Shawmarie Mayrand-Chung, Kiminori Nakamura, Hiroyoshi Nishikawa, A Karolina Palucka, Emanuel F Petricoin, Zoltan Pos, Antoni Ribas, Licia Rivoltini, Noriyuki Sato, Hiroshi Shiku, Craig L Slingluff, Howard Streicher, David F Stroncek, Hiroya Takeuchi, Minoru Toyota, Hisashi Wada, Xifeng Wu, Julia Wulfkuhle, Tomonori Yaguchi, Benjamin Zeskind, Yingdong Zhao, Mai-Britt Zocca & Francesco M Marincola. (2009) Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology. Journal of Translational Medicine 7:1.
Crossref
Crossref
Camilla Jandus, Daniel Speiser & Pedro Romero. (2009) Recent advances and hurdles in melanoma immunotherapy. Pigment Cell & Melanoma Research 22:6, pages 711-723.
Crossref
Crossref
Juliet C. Gray & Janice A. Kohler. (2009) Immunotherapy for neuroblastoma: Turning promise into reality. Pediatric Blood & Cancer 53:6, pages 931-940.
Crossref
Crossref
Catherine Gérard & Channa Debruyne. (2009) Immunotherapy in the landscape of new targeted treatments for non‐small cell lung cancer. Molecular Oncology 3:5-6, pages 409-424.
Crossref
Crossref
Jason A. Dubovsky, Douglas G. McNeel, John J. Powers, John Gordon, Eduardo M. Sotomayor & Javier A. Pinilla-Ibarz. (2009) Treatment of Chronic Lymphocytic Leukemia with a Hypomethylating Agent Induces Expression of NXF2, an Immunogenic Cancer Testis Antigen. Clinical Cancer Research 15:10, pages 3406-3415.
Crossref
Crossref